EM-1421

DRUG2 trials

Sponsors

Erimos Pharmaceuticals

Conditions

CancerCervical Intraepithelial Neoplasia

Phase 1

A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia

CompletedNCT00154089

Erimos PharmaceuticalsCervical Intraepithelial Neoplasia

Start: 2004-11-30End: 2006-12-31Updated: 2016-02-23

Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors

CompletedNCT00259818

Erimos PharmaceuticalsCancer

Start: 2005-12-31End: 2008-01-31Target: 30Updated: 2008-01-24